Astrana Health Inc (STU:3AM)

€ 40.2 -0.2 (-0.5%) Market Cap: 1.87 Bil Enterprise Value: 1.99 Bil PE Ratio: 33.27 PB Ratio: 2.93 GF Score: 77/100

Q3 2024 Astrana Health Inc Earnings Call Transcript
Nov 07, 2024

€55 (+1.85%)

Earnings
Q2 2024 Astrana Health Inc Earnings Call Transcript
Aug 07, 2024

€42.2 (-4.09%)

Earnings
Q1 2024 Astrana Health Inc Earnings Call Transcript
May 07, 2024

€35.2 (+0.57%)

Earnings
Q4 2023 Apollo Medical Holdings Inc Earnings Call Transcript
Feb 27, 2024

€38.8 (+4.30%)

Earnings
Apollo Medical Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Apollo Medical Holdings Inc Earnings Call Transcript
Nov 07, 2023

€27.2 (-8.11%)

Earnings
Apollo Medical Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Q2 2023 Apollo Medical Holdings Inc Earnings Call Transcript
Aug 07, 2023

€34.2

Earnings
Q1 2023 Apollo Medical Holdings Inc Earnings Call Transcript
May 08, 2023

€31.6 (+1.28%)

Earnings
Apollo Medical Holdings Inc at Barclays Global Healthcare Conference Transcript
Mar 14, 2023
Q4 2022 Apollo Medical Holdings Inc Earnings Call Transcript
Feb 24, 2023

€30.95 (-0.80%)

Earnings
Apollo Medical Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Apollo Medical Holdings Inc Earnings Call Transcript
Nov 04, 2022

€33.81 (-4.17%)

Earnings
Q2 2022 Apollo Medical Holdings Inc Earnings Call Transcript
Aug 04, 2022

€55.52 (+0.98%)

Earnings
Apollo Medical Holdings Inc at UBS Global Healthcare Conference Transcript
May 23, 2022
Q1 2022 Apollo Medical Holdings Inc Earnings Call Transcript
May 05, 2022

€37.26 (+4.22%)

Earnings
Apollo Medical Holdings Inc at Barclays Global Healthcare Conference Transcript
Mar 16, 2022
Q4 2021 Apollo Medical Holdings Inc Earnings Call Transcript
Feb 24, 2022

€44.2 (-6.36%)

Earnings
Apollo Medical Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Apollo Medical Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021
Q3 2021 Apollo Medical Holdings Inc Earnings Call Transcript
Nov 04, 2021

€65 (+5.69%)

Earnings
Apollo Medical Holdings Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 29, 2021
Apollo Medical Holdings Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021
Q1 2021 Apollo Medical Holdings Inc Earnings Call Transcript
May 05, 2021

Earnings

Q2 2024 Astrana Health Inc Earnings Call Transcript

Aug 07, 2024 / 09:30PM GMT

Release Date Price: €42.2 (-4.09%)

Transcript 10-Q8-K

Operator

Good day, everyone, and welcome to today's Astrana Health Second Quarter 2024 earnings call. (Operator Instructions) Today's speakers will be Brandon Sim, President and Chief Executive Officer of Astrana Health; and Chan Basho, our Chief Operating and Financial Officer.

The press release announcing Astrana Health Inc's results for the second quarter ended June 30, 2024, is available at the Investors section of the company's website at www.astranahealth.com. The company will discuss certain non-GAAP measures during this call.

Reconciliations to the most comparable GAAP measure are included in the press release to provide some additional background on its results. The company has made a supplemental deck available on its website. A replay of this broadcast will also be made available at a strong health website after the conclusion of this call.

Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed herein contains certain forward-looking

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.